Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices?
Nov 13, 2008 09:30 AM
- Noteworthy Developments in Biotech - Zacks Analyst Interviews
Nov 03, 2008 01:05 PM
- ViroPharma - Bull Of The Day
Oct 30, 2008 11:46 AM
- ViroPharma Makes the Right Moves - Analyst Blog
Oct 15, 2008 09:51 AM
- Nine Stocks To Watch, Still Nothing Mind-Blowing
Aug 21, 2008 10:25 AM
- Analyst Comments: Optimer Pharma, CREE, Delphi Financial, VeraSun, InterDigital, Greenfield Online
Aug 14, 2008 01:10 AM
- ViroPharma Cheap and Promising
Aug 04, 2008 02:08 AM
- Accumulating Paper
Jul 08, 2008 02:34 PM
- ViroPharma Value Worth Buying
Jun 24, 2008 03:55 PM
- Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin Lymphoma Data at International Conference on Malignant Lymphoma and Published Third Party, Independent Research Corroborates Promise of TAP Cancer Therapeutic as a Therapy for the Treatment of Cancer
Jun 05, 2008 09:59 AM
- ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
Dec 01, 2008 05:21 PM
- ViroPharma To Present At The 20th Annual Piper Jaffray Healthcare Conference
Nov 25, 2008 03:09 PM
- ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
Nov 12, 2008 09:03 AM
- ViroPharma to Present at Three November Healthcare Conferences
Nov 06, 2008 03:32 PM
- ViroPharma to Discuss Commercialization and Launch of Cinryze(TM) on November 5, 2008
Oct 30, 2008 01:13 PM
- ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
Oct 29, 2008 07:31 AM
- ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
Oct 21, 2008 03:04 PM
- ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
Oct 20, 2008 07:31 AM
- ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
Oct 14, 2008 01:30 PM
- ViroPharma to Present at Three October Healthcare Conferences
Oct 01, 2008 09:42 AM
- Form 4 VIROPHARMA INC For: Nov 07 Filed by: DE ROSEN MICHEL (10K)
Nov 12, 2008 02:12 PM
- Form 4 VIROPHARMA INC For: Nov 03 Filed by: Rowland Charles A Jr (10K)
Nov 05, 2008 04:23 PM
- Form 4 VIROPHARMA INC For: Nov 03 Filed by: DOUGHERTY MICHAEL R (10K)
Nov 05, 2008 04:17 PM
- Form 4 VIROPHARMA INC For: Oct 21 Filed by: BAKER JULIAN (10K)
Oct 21, 2008 09:01 PM
- Form 4 Rowland Charles A Jr For: Oct 20 (10K)
Oct 21, 2008 06:45 PM
- Form 3 Rowland Charles A Jr For: Oct 20 (10K)
Oct 21, 2008 06:42 PM
- Form 3/A VIROPHARMA INC For: Mar 20 Filed by: BAKER JULIAN (10K)
Oct 17, 2008 06:00 PM
- Form 3/A VIROPHARMA INC For: Mar 20 Filed by: BAKER FELIX (10K)
Oct 17, 2008 05:48 PM
- Form 4 Broom Colin MD For: Sep 12 (10K)
Sep 16, 2008 06:29 PM
- Form 4 Morris Richard Steven For: Sep 11 (10K)
Sep 15, 2008 04:11 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
VPHM
|
Compare to S&P
|
| YTD |
42.32 %
|
133.17 %
|
| 4 Weeks |
-9.89 %
|
-2.60 %
|
| 12 Weeks |
-19.86 %
|
11.09 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 10.00 %
|
|
EPS Growth in Last Year: 26.92 %
|
|
Sales Growth in Last Quarter: 0.73 %
|
|
Sales Growth in Last Quarter: 29.38 %
|
|
|
